Form 4: Life360 Director Sells Shares Under 10b5-1 Plan

Life360 Director Charles J. Prober exercised stock options and sold an equal number of common shares on November 13, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Charles J. Prober, a Director of Life360, Inc. (LIF), reported transactions on November 13, 2025, executed under a Rule 10b5-1 trading plan adopted on March 14, 2025.
• Prober acquired 7,930 shares of common stock by exercising stock options at a price of $11.18 per share.
• Concurrently, Prober disposed of 7,930 shares of common stock at a price of $76.93 per share.
• Following these transactions, Prober beneficially owns 105,456 shares of common stock directly, which includes 2,036 restricted stock units (RSUs).
• Prober retains 95,160 stock options after the reported exercise.
• The vesting commencement date for the stock option was corrected to April 1, 2024, from the previously reported April 12, 2024.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (option exercise and sale) executed under a pre-established 10b5-1 trading plan, which is generally considered neutral as it's not indicative of new sentiment or a reaction to recent material nonpublic information.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned sales and reducing concerns about insider trading based on material nonpublic information.
• The director realized a significant profit by exercising options at $11.18 and selling shares at $76.93.

Negatives

• An insider selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, though it is often for personal financial planning or diversification.

Future Outlook

This Form 4 filing does not contain explicit forward-looking statements or guidance regarding the company's future performance or strategic direction. It primarily reports past insider transactions.

Management Comments

• The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.
• The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria.
• The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
• The vesting commencement date for the stock option was inadvertently reported as April 12, 2024, on the Reporting Person's initial Form 3 and subsequent Forms 4, and has been corrected to April 1, 2024, as of this Form 4.

Industry Context

Insider transaction reports (Form 4s) are standard regulatory filings for publicly traded companies. The use of a Rule 10b5-1 trading plan is a common practice among corporate insiders to manage their equity holdings in compliance with insider trading regulations, allowing for pre-scheduled sales or purchases.

Corporate Governance

Stakeholder Impact

• Shareholders: May note the director's sale of shares, but the execution under a 10b5-1 plan typically mitigates concerns about the sale being based on new, negative material information. The profit realized by the director reflects the company's stock performance.

Next Steps

• The remaining 95,160 stock options will continue to vest according to their schedule, with 1/48th of the total shares vesting in equal monthly installments after the initial 1/2 vested on April 1, 2024, subject to the director's continuing service.

Key Dates

Keywords

Life360, LIF, Form 4, Insider Transaction, Stock Option Exercise, Share Sale, 10b5-1 Plan, Director Transaction, Beneficial Ownership